{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:55:59Z","timestamp":1769064959202,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.amjms.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T17:50:48Z","timestamp":1747590648000},"page":"245-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic value of FeNO, periostin, IL-4, and ECP in patients with acute exacerbation of bronchial asthma"],"prefix":"10.1016","volume":"370","author":[{"given":"Menglong","family":"Feng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingqin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaben","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0001","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.alit.2020.08.001","article-title":"Japanese guidelines for adult asthma 2020","volume":"69","author":"Nakamura","year":"2020","journal-title":"Allergol Int: Official J Japanese Society of Allergol"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0002","first-page":"918","article-title":"Asthma Exacerbations: pathogenesis, prevention, and treatment. The journal of allergy and clinical immunology","volume":"5","author":"Castillo","year":"2017","journal-title":"In Pract"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0003","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.chest.2022.02.029","article-title":"Management of life-threatening asthma: severe asthma Series","volume":"162","author":"Garner","year":"2022","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.amjms.2025.05.005_bib0004","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S2213-2600(24)00299-6","article-title":"Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial","volume":"13","author":"Ramakrishnan","year":"2025","journal-title":"Lancet Respirat Med"},{"issue":"5","key":"10.1016\/j.amjms.2025.05.005_bib0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0042-1743290","volume":"43","author":"Loewenthal","year":"2022","journal-title":"FeNO in Asthma Seminars Respirat Critical Care Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.05.005_bib0006","first-page":"166","article-title":"Trajectory of spirometric and exhaled nitric oxide measurements in Chinese schoolchildren with asthma. Pediatric allergy and immunology: official publication of the European Society of Pediatric","volume":"29","author":"Leung","year":"2018","journal-title":"Allergy Immunol"},{"issue":"2","key":"10.1016\/j.amjms.2025.05.005_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.amjms.2025.05.005_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13081428","article-title":"Update on the role of FeNO in asthma management","volume":"13","author":"Murugesan","year":"2023","journal-title":"Diagnostics"},{"issue":"3","key":"10.1016\/j.amjms.2025.05.005_bib0009","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.resinv.2020.02.003","article-title":"Role of serum periostin in the management of asthma and its comorbidities","volume":"58","author":"Matsumoto","year":"2020","journal-title":"Respir Investig"},{"issue":"1","key":"10.1016\/j.amjms.2025.05.005_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-015-0218-2","article-title":"Periostin: its role in asthma and its potential as a diagnostic or therapeutic target","volume":"16","author":"Li","year":"2015","journal-title":"Respir Res"},{"key":"10.1016\/j.amjms.2025.05.005_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.alit.2015.04.012","article-title":"Recent developments regarding periostin in bronchial asthma","volume":"64","author":"Izuhara","year":"2015","journal-title":"Allergol Int: Official J Japanese Society Allergol"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2500\/aap.2020.41.200038","article-title":"The role of serum periostin in the diagnosis of asthma: a meta-analysis","volume":"41","author":"Yang","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.amjms.2025.05.005_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108348","article-title":"Interleukin-4 as a therapeutic target","volume":"242","author":"Gartner","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.amjms.2025.05.005_bib0014","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.13444","article-title":"IL-4\/IL-13 axis as therapeutic targets in allergic rhinitis and asthma","volume":"10","author":"Nur Husna","year":"2022","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0015","doi-asserted-by":"crossref","first-page":"14279","DOI":"10.4238\/2015.November.13.11","article-title":"Eosinophil cationic protein mRNA expression in children with bronchial asthma","volume":"14","author":"Yu","year":"2015","journal-title":"Genetics Molec Res"},{"issue":"7","key":"10.1016\/j.amjms.2025.05.005_bib0016","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/j.jaip.2021.02.053","article-title":"Performance of eosinophil cationic protein as a biomarker in asthmatic children","volume":"9","author":"Shah","year":"2021","journal-title":"J Allergy Clin Immunol Practice"},{"issue":"3","key":"10.1016\/j.amjms.2025.05.005_bib0017","first-page":"325","article-title":"Risk of asthma exacerbation associated with opioid and nonopioid analgesic use in children with current asthma","volume":"28","author":"Nair","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"issue":"2","key":"10.1016\/j.amjms.2025.05.005_bib0018","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/ACI.0000000000000512","article-title":"Management of acute loss of asthma control: yellow zone strategies","volume":"19","author":"Polk","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.amjms.2025.05.005_bib0019","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccm.2020.06.007","article-title":"Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations","volume":"41","author":"Ritchie","year":"2020","journal-title":"Clin. Chest Med."},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/1568010054526359","article-title":"Nitric oxide production and signaling in inflammation","volume":"4","author":"Korhonen","year":"2005","journal-title":"Current Drug Targets Inflamm Allergy"},{"issue":"11","key":"10.1016\/j.amjms.2025.05.005_bib0021","article-title":"Exhaled nitric oxide levels to guide treatment for children with asthma","volume":"11","author":"Petsky","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.amjms.2025.05.005_bib0022","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1136\/jim-2017-000680","article-title":"Increased expression of serum periostin and YKL40 in children with severe asthma and asthma exacerbation","volume":"66","author":"El Basha","year":"2018","journal-title":"J Investig Med: Official Publicat Am Federation Clin Res"},{"issue":"21","key":"10.1016\/j.amjms.2025.05.005_bib0023","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.neuron.2023.09.031","article-title":"IL-4 shapes microglia-dependent pruning of the cerebellum during postnatal development","volume":"111","author":"Guedes","year":"2023","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1398-9995.2007.01327.x","article-title":"Eosinophil cationic protein (ECP) polymorphisms and association with asthma, s-ECP levels and related phenotypes","volume":"62","author":"Munthe-Kaas","year":"2007","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.amjms.2025.05.005_bib0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/rmed.2001.1123","article-title":"Eosinophil cationic protein (ECP) in saliva: a new marker of disease activity in bronchial asthma","volume":"95","author":"Schmekel","year":"2001","journal-title":"Respir Med"},{"issue":"19","key":"10.1016\/j.amjms.2025.05.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38875","article-title":"The change of FeNO is correlated with asthma control and lung function","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.amjms.2025.05.005_bib0027","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-981-13-6657-4_15","article-title":"Roles of periostin in asthma","volume":"1132","author":"Matsumoto","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.amjms.2025.05.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156091","article-title":"IL-4 and IL-13, not eosinophils, drive type 2 airway inflammation, remodeling and lung function decline","volume":"162","author":"Scott","year":"2023","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.amjms.2025.05.005_bib0029","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1620\/tjem.242.263","article-title":"Serum eosinophil cationic protein is a useful marker for assessing the efficacy of inhaled corticosteroid therapy in children with bronchial asthma","volume":"242","author":"Guo","year":"2017","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"10.1016\/j.amjms.2025.05.005_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/02770903.2017.1318141","article-title":"Elevated serum levels of TNF-alpha, IL-8, and ECP can be involved in the development and progression of bronchial asthma","volume":"55","author":"Jiang","year":"2018","journal-title":"J Asthma: Official J Associat Care of Asthma"},{"issue":"7","key":"10.1016\/j.amjms.2025.05.005_bib0031","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1159\/000521890","article-title":"Serum eosinophilic cationic protein is a reliable biomarker for childhood asthma","volume":"183","author":"Rydell","year":"2022","journal-title":"Int. Arch. Allergy Immunol."}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925010389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T14:34:05Z","timestamp":1755614045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925010389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0002962925010389"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.05.005","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic value of FeNO, periostin, IL-4, and ECP in patients with acute exacerbation of bronchial asthma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}